Real-world Evidence Study on Cystistat

Active, not recruitingOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

October 21, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

March 31, 2025

Conditions
Interstitial Cystitis and Bladder Pain Syndrome
Interventions
DEVICE

intravesical sodium hyaluronate (Cystistat®)

Cystistat will be instilled into the bladder according to the instructions for use and in line with the routine clinical practice.

Trial Locations (1)

Unknown

Medical University of Vienna, Vienna

All Listed Sponsors
lead

MEDA Pharma GmbH & Co. KG

INDUSTRY